Literature DB >> 26149026

Fibrinogen, red blood cells, and factor XIII in venous thrombosis.

B L Walton1, J R Byrnes1, A S Wolberg1.   

Abstract

Cardiovascular disease is the leading cause of death and disability worldwide. Among cardiovascular causes of death, venous thrombosis (VT) is ranked third most common in the world. Venous thrombi have high red blood cell and fibrin content; however, the pathophysiologic mechanisms that contribute to venous thrombus composition and stability are still poorly understood. This article reviews biological, biochemical, and biophysical contributions of fibrinogen, factor XIII, and red blood cells to VT, and new evidence suggesting interactions between these components mediate venous thrombus composition and size.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  clot retraction; factor XIII; fibrinogen; platelet; red blood cell; venous thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26149026      PMCID: PMC5975093          DOI: 10.1111/jth.12918

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  85 in total

1.  Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin.

Authors:  Patricia Hermand; Pierre Gane; Martine Huet; Vincent Jallu; Cécile Kaplan; H H Sonneborn; Jean-Pierre Cartron; Pascal Bailly
Journal:  J Biol Chem       Date:  2002-12-10       Impact factor: 5.157

2.  Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.

Authors:  Bernard C B Lim; Robert A S Ariëns; Angela M Carter; John W Weisel; Peter J Grant
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

3.  Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.

Authors:  P E J Van Der Meijden; M Van Schilfgaarde; R Van Oerle; T Renné; H ten Cate; H M H Spronk
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

Review 4.  Thrombin generation and fibrin clot structure.

Authors:  Alisa S Wolberg
Journal:  Blood Rev       Date:  2007-01-08       Impact factor: 8.250

Review 5.  The pleiotropic role of the fibrinogen gamma' chain in hemostasis.

Authors:  Shirley Uitte de Willige; Kristina F Standeven; Helen Philippou; Robert A S Ariëns
Journal:  Blood       Date:  2009-08-17       Impact factor: 22.113

6.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

7.  Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.

Authors:  P W Kamphuisen; J C Eikenboom; H L Vos; R Pablo; A Sturk; R M Bertina; F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

Review 8.  Venous thromboembolic events and erythropoiesis-stimulating agents: an update.

Authors:  Mario Dicato
Journal:  Oncologist       Date:  2008

9.  Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

Authors:  Kellie R Machlus; Jessica C Cardenas; Frank C Church; Alisa S Wolberg
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

10.  Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function.

Authors:  Cédric Duval; Peter Allan; Simon D A Connell; Victoria C Ridger; Helen Philippou; Robert A S Ariëns
Journal:  Thromb Haemost       Date:  2014-01-16       Impact factor: 5.249

View more
  19 in total

1.  Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.

Authors:  L G Poole; A Pant; K S Baker; A K Kopec; H M Cline-Fedewa; S E Iismaa; M J Flick; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2018-12-10       Impact factor: 5.824

Review 2.  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Eur J Med Chem       Date:  2020-05-18       Impact factor: 6.514

Review 3.  Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.

Authors:  Alisa S Wolberg; Yaqiu Sang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-06-02       Impact factor: 10.514

4.  Perioperative Transfusions and Venous Thromboembolism.

Authors:  Ruchika Goel; Cassandra D Josephson; Eshan U Patel; Molly R Petersen; Sarah Makhani; Steven M Frank; Paul M Ness; Evan M Bloch; Eric A Gehrie; Parvez M Lokhandwala; Marianne M Nellis; Oliver Karam; Beth H Shaz; Ravi M Patel; Aaron A R Tobian
Journal:  Pediatrics       Date:  2020-03-20       Impact factor: 7.124

Review 5.  Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2016-05-04       Impact factor: 4.180

6.  Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy.

Authors:  Wan-Ching Cheng; Lois Wilkie; Tsumugi Anne Kurosawa; Melanie Dobromylskyj; Simon Lawrence Priestnall; Virginia Luis Fuentes; David J Connolly
Journal:  Animals (Basel)       Date:  2021-04-26       Impact factor: 2.752

Review 7.  Amylin Dyshomeostasis Hypothesis: Small Vessel-Type Ischemic Stroke in the Setting of Type-2 Diabetes.

Authors:  Florin Despa; Larry B Goldstein
Journal:  Stroke       Date:  2021-05-05       Impact factor: 10.170

8.  Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS).

Authors:  Janette Bester; Prashilla Soma; Douglas B Kell; Etheresia Pretorius
Journal:  Oncotarget       Date:  2015-11-03

Review 9.  Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.

Authors:  Tomas Simurda; Monika Brunclikova; Rosanna Asselta; Sonia Caccia; Jana Zolkova; Zuzana Kolkova; Dusan Loderer; Ingrid Skornova; Jan Hudecek; Zora Lasabova; Jan Stasko; Peter Kubisz
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

10.  Predicting value of fibrinogen in identifying cerebrovascular ischemic events in patients with dizziness/vertigo.

Authors:  You Wang; Xueling Zhou; Yong Luo
Journal:  Neurol Sci       Date:  2021-06-15       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.